SVT-40776 in Patients Suffering From Overactive Bladder Syndrome.
Phase of Trial: Phase II
Latest Information Update: 26 Oct 2011
At a glance
- Drugs Tarafenacin (Primary) ; Tolterodine
- Indications Overactive bladder
- Focus Therapeutic Use
- 07 Jun 2011 Actual end date (Sep 2007) added as reported by ClinicalTrials.gov.
- 07 Jun 2011 Additional lead trial centre and actual initiation date (Sep 2006) identified as reported by ClinicalTrials.gov.
- 07 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.